Judith L. Swain

Director at Lexicon Pharmaceuticals · 1 reported transaction in 1 company · latest report Jun 3, 2026

Their trades


Lexicon PharmaceuticalsLXRX	Exercised options — · 89,312 shares	Jun 3, 2026

Jun 3, 2026 · LXRX

89,312

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Lexicon Pharmaceuticals · 1 reported transaction in 1 company · latest report Jun 3, 2026


Lexicon PharmaceuticalsLXRX	Exercised options — · 89,312 shares	Jun 3, 2026

Jun 3, 2026 · LXRX

89,312

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.